Caring Brands, Inc.
$1.25
▲
1.83%
2026-04-21 05:52:00
www.Caringbrands.com
NCM: CABR
Explore Caring Brands, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
$1.25
52W High / Low
$6 / $0.06
Stock P/E
—
Book Value
$0.14
Dividend Yield
—
ROCE
-157.44%
ROE
-2.17%
Face Value
—
EPS
$-0.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
—
Beta
—
Debt / Equity
2.8
Current Ratio
13.16
Quick Ratio
13.09
Forward P/E
—
Price / Sales
4,125.64
Enterprise Value
$12.43 M
EV / EBITDA
-4.03
EV / Revenue
2,949.56
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ANI Pharmaceuticals, Inc. | $81.73 | 23.13 | $1.81 B | 0.06% | 6.99% | 16.16% | $99.5 / $56.71 | $25.8 |
| 2. | Aquestive Therapeutics, Inc. | $4.24 | — | $527.23 M | — | -62.98% | 178.61% | $7.55 / $2.12 | $-0.28 |
| 3. | InterCure Ltd. | $0.75 | — | $125.93 M | — | -8.41% | -16.68% | $605 / $225.3 | $7.59 |
| 4. | Journey Medical Corporation | $5.19 | — | $147.31 M | — | -14.3% | -44.03% | $9.55 / $4.31 | $1.17 |
| 5. | Eton Pharmaceuticals, Inc. | $25.28 | — | $683.2 M | — | -1.57% | -18.19% | $27.29 / $13.09 | $0.97 |
| 6. | Neurocrine Biosciences, Inc. | $130.77 | 28.05 | $13.18 B | — | 16.37% | 16.38% | $160.18 / $98.95 | $32.5 |
| 7. | Esperion Therapeutics, Inc. | $2.02 | — | $510.15 M | — | 36.51% | 6.57% | $4.17 / $0.69 | $-1.23 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -1.19 M | -1 M | -0.87 M | -0.16 M |
| Net Profit | -4.06 M | -1.02 M | -0.86 M | -0.16 M |
| EPS in Rs | -0.33 | -0.08 | -0.07 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 0 M | 0 M | 0.02 M |
| Operating Profit | -3.39 M | -1.53 M | -0.15 M |
| Net Profit | -6.28 M | -1.52 M | -0.13 M |
| EPS in Rs | -0.51 | -0.12 | -0.01 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 2.33 M | 3.88 M | 0.02 M |
| Total Liabilities | 0.24 M | 0.19 M | 0.29 M |
| Equity | 2.09 M | 3.69 M | -0.27 M |
| Current Assets | 2.33 M | 0.53 M | 0.02 M |
| Current Liabilities | 0.18 M | 0.19 M | 0.02 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | -1.69 M | -0.82 M | -0.06 M |
| Investing CF | 0 M | 0.61 M | 0.04 M |
| Financing CF | 3.41 M | 0.67 M | 0.02 M |
| Free CF | -1.69 M | -0.82 M | -0.06 M |
| Capex | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 806.45% | -97.72% | — |
| Earnings Growth % | -313.74% | -1084.7% | — |
| Profit Margin % | -148948.78% | -326329.25% | -627.23% |
| Operating Margin % | -80309.02% | -328471.83% | -741.36% |
| Gross Margin % | 55.56% | -345.59% | -482.12% |
| EBITDA Margin % | -73191.58% | -296213.76% | -730.59% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.